159 related articles for article (PubMed ID: 38341472)
21. High expression of TCF12 contributes to gastric cancer development via being target regulated by miR-183 and activating PI3K/AKT pathway.
Wang X; Gao S; Xie F; Li W; Li M; Yan N; Gao T; Fang L
J Cell Biochem; 2019 Aug; 120(8):13903-13911. PubMed ID: 30982999
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of SDCBP inhibits cell proliferation and induces apoptosis by regulating PI3K/AKT/mTOR pathway in gastric carcinoma.
Qian B; Yao Z; Yang Y; Li N; Wang Q
Biotechnol Appl Biochem; 2022 Feb; 69(1):240-247. PubMed ID: 33432665
[TBL] [Abstract][Full Text] [Related]
23. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
[TBL] [Abstract][Full Text] [Related]
24. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
Gu Y; Fei Z; Zhu R
Anticancer Drugs; 2020 Apr; 31(4):385-393. PubMed ID: 31913198
[TBL] [Abstract][Full Text] [Related]
25. HOXB13 promotes gastric cancer cell migration and invasion via IGF-1R upregulation and subsequent activation of PI3K/AKT/mTOR signaling pathway.
Guo C; Chu H; Gong Z; Zhang B; Li C; Chen J; Huang L
Life Sci; 2021 Aug; 278():119522. PubMed ID: 33894267
[TBL] [Abstract][Full Text] [Related]
26. PGAM5 promotes tumorigenesis of gastric cancer cells through PI3K/AKT pathway.
Meng L; Hu P; Xu A
Pathol Res Pract; 2023 Apr; 244():154405. PubMed ID: 36889176
[TBL] [Abstract][Full Text] [Related]
27. miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway.
Riquelme I; Tapia O; Leal P; Sandoval A; Varga MG; Letelier P; Buchegger K; Bizama C; Espinoza JA; Peek RM; Araya JC; Roa JC
Cell Oncol (Dordr); 2016 Feb; 39(1):23-33. PubMed ID: 26458815
[TBL] [Abstract][Full Text] [Related]
28. Ox-LDL-mediated ILF3 overexpression in gastric cancer progression by activating the PI3K/AKT/mTOR signaling pathway.
Sun D; Zhang M; Wei M; Wang Z; Qiao W; Liu P; Zhong X; Liang Y; Chen Y; Huang Y; Yu W
Aging (Albany NY); 2022 May; 14(9):3887-3909. PubMed ID: 35507914
[TBL] [Abstract][Full Text] [Related]
29. Topoisomerase II alpha promotes gallbladder cancer proliferation and metastasis through activating phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway.
Lyu WJ; Shu YJ; Liu YB; Dong P
Chin Med J (Engl); 2020 Oct; 133(19):2321-2329. PubMed ID: 32925281
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA TMPO-AS1/miR-126-5p/BRCC3 axis accelerates gastric cancer progression and angiogenesis via activating PI3K/Akt/mTOR pathway.
Hu Y; Zhang Y; Ding M; Xu R
J Gastroenterol Hepatol; 2021 Jul; 36(7):1877-1888. PubMed ID: 33295056
[TBL] [Abstract][Full Text] [Related]
31. Tensin4 promotes invasion and migration of gastric cancer cells via regulating AKT/GSK-3β/snail signaling pathway.
Qi X; Sun L; Wan J; Xu R; He S; Zhu X
Pathol Res Pract; 2020 Jul; 216(7):153001. PubMed ID: 32534709
[TBL] [Abstract][Full Text] [Related]
32. SERPINA5 promotes tumour cell proliferation by modulating the PI3K/AKT/mTOR signalling pathway in gastric cancer.
Fan M; Xiong X; Han L; Zhang L; Gao S; Liu L; Wang X; Huang C; Tong D; Yang J; Zhao L; Shao Y
J Cell Mol Med; 2022 Sep; 26(18):4837-4846. PubMed ID: 36000536
[TBL] [Abstract][Full Text] [Related]
33. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
34. SPI1 Mediates N-Myristoyltransferase 1 to Advance Gastric Cancer Progression via PI3K/AKT/mTOR Pathway.
Qiu P; Li X; Gong M; Wen P; Wen J; Xu L; Wang G
Can J Gastroenterol Hepatol; 2023; 2023():2021515. PubMed ID: 36967718
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-183 affects the development of gastric cancer by regulating autophagy via MALAT1-miR-183-SIRT1 axis and PI3K/AKT/mTOR signals.
Li H; He C; Wang X; Wang H; Nan G; Fang L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3163-3171. PubMed ID: 31352788
[TBL] [Abstract][Full Text] [Related]
36. Loss of G3BP1 suppresses proliferation, migration, and invasion of esophageal cancer cells via Wnt/β-catenin and PI3K/AKT signaling pathways.
Zhang LN; Zhao L; Yan XL; Huang YH
J Cell Physiol; 2019 Nov; 234(11):20469-20484. PubMed ID: 30989663
[TBL] [Abstract][Full Text] [Related]
37. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
[TBL] [Abstract][Full Text] [Related]
38. KIRREL promotes the proliferation of gastric cancer cells and angiogenesis through the PI3K/AKT/mTOR pathway.
Wang T; Chen S; Wang Z; Li S; Fei X; Wang T; Zhang M
J Cell Mol Med; 2024 Jan; 28(1):e18020. PubMed ID: 37909722
[TBL] [Abstract][Full Text] [Related]
39. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
Yin F; Huang X; Xuan Y
Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817
[TBL] [Abstract][Full Text] [Related]
40. Nucleoporin 37 promotes the cell proliferation, migration, and invasion of gastric cancer through activating the PI3K/AKT/mTOR signaling pathway.
Zhang J; Lv W; Liu Y; Fu W; Chen B; Ma Q; Gao X; Cui X
In Vitro Cell Dev Biol Anim; 2021 Dec; 57(10):987-997. PubMed ID: 34888748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
